SOURCE: NexMed, Inc.

May 05, 2006 08:31 ET

NexMed to Report First Quarter 2006 Financial Results on Tuesday, May 9, 2006

EAST WINDSOR, NJ -- (MARKET WIRE) -- May 5, 2006 -- NexMed, Inc. (NASDAQ: NEXM), a developer of innovative pharmaceutical products based on its proprietary NexACT® transdermal drug delivery technology, today announced that on Tuesday, May 9, 2006, it expects to report its first quarter 2006 results at 8:30a.m.EST and hold its management conference call at 9:00a.m.EST. The Company intends to file its Form 10-Q for the quarter ended March 31, 2006 on the same day. The call can be accessed in the U.S. by dialing 877-407-9205 and outside of the U.S. by dialing 201-689-8054 and asking the conference operator for the NexMed Conference Call. The conference call will also be Webcast live at http://www.vcall.com/IC/CEPage.asp?ID=104507. Playback is available until May 17, 2006, by dialing in the U.S. 877-660-6853 and outside of the U.S. by dialing 201-612-7415. Replay pass codes 286 and 201870 are both required for playback.

About NexMed, Inc.

NexMed, an innovative drug developer, offers large pharmaceutical companies the opportunity to save considerably on R&D costs, develop new patient-friendly transdermal products, and extend patent lifespans and brand equity, through participation in early stage licensing and development partnerships. NexMed currently has a host of medicines in development, such as treatments for nail fungus, sexual disorders and more, all based on its proprietary NexACT® drug delivery technology.

Contact Information

  • Contacts:
    Deborah Carty
    NexMed, Inc.
    (609) 371-8123 x 159
    Email Contact